Safety and efficacy of nivolumab in patients with metastatic renal cell carcinoma treated beyond progression Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Carcinoma, Renal Cell
  • Kidney Neoplasms

abstract

  • clinicaltrials.gov Identifier: NCT01354431.

publication date

  • September 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5568541

Digital Object Identifier (DOI)

  • 10.1001/jamaoncol.2016.0775

PubMed ID

  • 27243803

Additional Document Info

start page

  • 1179

end page

  • 86

volume

  • 2

number

  • 9